Sutro Biopharma, Inc. · NASDAQ:STRO
Affinity Asset Advisors, LLC reported a 8.80% stake in Sutro Biopharma, Inc. (Schedule 13G/A)
Event Jan 22, 2026 · Filed Jan 29, 2026
Affinity Asset Advisors, LLC reported a 8.80% stake in Sutro Biopharma, Inc., 748,382 shares, as a passive investor on Jan 22, 2026. Filed Jan 29, 2026 (Schedule 13G/A).
- Stake
- 8.80%
- Shares
- 748,382
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Affinity Asset Advisors, LLC | 8.80% | 748,382 |
| Michael Cho | 8.80% | 748,382 |
Source
Related
- Sutro Biopharma, Inc.
- Affinity Asset Advisors, LLC
- Sutro Biopharma, Inc. shareholders
- Schedule 13G/A · Affinity Asset Advisors, LLC · May 14, 2026
- Form 4 · Gerber Hans-Peter · Sep 22, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · Aug 14, 2026
- Schedule 13G/A · Perceptive Advisors LLC · Aug 14, 2026
- Schedule 13G · BlackRock, Inc. · Jul 30, 2026
- Form 4 · Chow Gregory K. · Jun 2, 2026